Floré key facts
as of Oct 2026- Producer of custom probiotics intended for improving gut health.
- Floré is valued at approximately $35.0M as of Oct 2026 (last reported valuation).
- It has raised $27.1M; the latest was Later Stage VC in Aug 2025.
- Notable investors include Plug and Play Tech Center, SOSV, IndieBio, CONNECT(San Diego), K3 Ventures — 15 tracked in total.
- Status: Privately Held (backing).
Floré's last reported valuation, Dec 2023. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch Floré: the Monday email on marks, rounds and moves
Floré funding rounds
No funding rounds for Floré are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Floré
15+Floré valuation
Floré's last reported valuation was $35 million in Dec 2023. No priced round, secondary trade or fund mark has surfaced since.
Floré investors
15 investors are on record for Floré, including Plug and Play Tech Center, SOSV, IndieBio and CONNECT(San Diego).
About Floré
Producer of custom probiotics intended for improving gut health. The company combines microbiome testing and different prebiotics, probiotics, and botanical ingredients to create a custom formulation, reduce constipation, relieve digestive issues, promote food tolerance, support GI motility, support digestive quality of life and support immunity, enabling individuals to address issues such as abdominal pain, constipation, bloating, small intestinal bacterial overgrowth, leaky gut, and other digestive issues.
- Sector
- Consumer Products and Services (B2C)
- HQ
- San Diego, CA, United States
- Founded
- 2016
- Employees
- 11
- Website
- flore.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.